Pharyngobasilar fascia (PBF)

• Thin, smooth, sharply defined enhancing layer at the nasopharyngeal wall on postcontrast fat-suppressed T1 MRI—this is the normal intact PBF
• Focal irregularity, interruption, or replacement of that smooth layer by enhancing tumor—indicates fascial breach and deep extension
• Loss of the normal fat-plane clarity between the nasopharynx and adjacent parapharyngeal or masticator spaces—suggests PBF disruption
• Asymmetric deep-wall extension, particularly around the sinus of Morgagni/torus tubarius region—the most common route for tumor egress

• On postcontrast fat-suppressed T1 MRI, the normal nasopharyngeal mucosa and pharyngobasilar fascia together appear as a thin, smooth, sharply demarcated enhancing layer; this is the hallmark of an intact, uninvaded PBF.
• The PBF lies in anatomic sequence from luminal to deep: mucosa/submucosa → pharyngobasilar fascia → superior constrictor → buccopharyngeal fascia → parapharyngeal/masticator spaces; disruption of this layering indicates transgression.
• The sinus of Morgagni is a crucial anterior-lateral deficiency in the PBF where the cartilaginous Eustachian tube and levator veli palatini traverse; this is the most common and clinically relevant route for nasopharyngeal carcinoma to extend into the parapharyngeal and masticator compartments.
• Nasopharyngeal carcinoma breaks through the PBF posterolaterally into the poststyloid parapharyngeal space and carotid space, or anterolaterally near the tubal region/sinus of Morgagni into the tensor/levator veli palatini, medial pterygoid, and masticator space.
• CT can infer PBF integrity indirectly by assessing preserved anatomy, absence of fat-plane obliteration, and lack of infiltration of adjacent soft tissues, though the fascia itself is often not directly separable from muscle on CT.
• Contrast-enhanced MRI is superior to CT for detecting subtle loss of the smooth, continuous PBF contour and for early detection of mucosal invasion by nasopharyngeal carcinoma.
• Breached PBF can provide access for deep extension toward the masticator compartment, V3 at the foramen ovale, pterygopalatine fossa, cavernous sinus, skull-base marrow, foramina, and perineural routes—requiring careful assessment of these regions.
• Benign lymphoid hyperplasia typically remains superficial to the dense PBF, whereas infiltrative masses with asymmetric deep extension, fascial disruption, parapharyngeal involvement, skull-base invasion, or cranial neuropathy indicate aggressive disease (malignant or severe inflammatory).

• Benign lymphoid hyperplasia vs. nasopharyngeal carcinoma: hyperplasia remains superficial to the PBF with smooth contours, whereas carcinoma disrupts the fascia with irregular deep extension and parapharyngeal space involvement.
• Superficial mucosal lesion (confined above PBF) vs. invasive mural disease (transgressing PBF): loss of the sharp, smooth enhancing layer is the key distinguishing feature of invasion.
• Inflammatory/infectious nasopharyngitis vs. malignancy: both can breach the PBF, but clinical context, pattern of edema/suppuration, marrow changes, and presence of cranial neuropathy help differentiate; clear fascial crossing implies an aggressive process.
• Early-stage nasopharyngeal carcinoma (mucosal/early stromal invasion) vs. advanced disease: intact or subtly disrupted PBF with normal deep-space fat planes favors early disease; clear fascial breach with parapharyngeal/masticator involvement indicates advanced disease.
• Primary nasopharyngeal process vs. secondary involvement from skull-base osteomyelitis/osteonecrosis: direct bone marrow involvement on T1/T2 and erosive cortical changes help distinguish primary infiltration from secondary spread through the PBF.

When describing nasopharyngeal tumor extension, use this language: "Nasopharyngeal tumor extends through the pharyngobasilar fascia at the [location: e.g., left torus tubarius/sinus of Morgagni], with involvement of the adjacent [muscles affected: levator/tensor veli palatini, medial pterygoid, etc.] and extension into the [deep space affected: prestyloid parapharyngeal space, masticator space, etc.]"—this clearly documents both the fascial breach site and the deep extent, which are critical for TNM staging and surgical planning.

• Mistaking benign lymphoid hyperplasia (which is superficial and maintains a smooth PBF) for invasive nasopharyngeal carcinoma; look for irregular fascial contour, deep asymmetric extension, and parapharyngeal involvement to confirm invasion.
• Overlooking the sinus of Morgagni as the site of fascial breach; tumor commonly extends through this anterior-lateral deficiency into the tensor/levator veli palatini and masticator space, so always scrutinize the torus tubarius region closely on axial and coronal images.
• Focusing only on the primary tumor and neglecting to assess for parapharyngeal space, skull-base, and foraminal involvement once PBF breach is identified; clear fascial disruption mandates systematic evaluation of potential deep-space and cranial-nerve extension routes.
• Relying on CT alone to assess PBF integrity; the fascia is often inseparable from adjacent muscle on CT, making the thin, enhancing MRI appearance on postcontrast fat-suppressed T1 imaging far more sensitive for detecting subtle invasion and early disease.